Editorial
 NO SLA FOR KERALA AYUSH SECTOR!   
 Wednesday, April 18, 2018 
 The Rs 1000-crore ayurveda industry in Kerala is in total disarray, thanks largely to the egoistic attitude of the state government which has refused to reinstate Dr. N Vimala as State Licensing Authority (SLA) for Ayush 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Study shows significant benefits of nasal high flow therapy for COPD patients using Fisher & Paykel’s myAirvo device
17:00  [IST]Asembia expands collaboration with Pfizer oncology
16:00  [IST]Sinovac Biotech reports preliminary results of phase III trial on Sabin inactivated polio vaccine
15:00  [IST]Zimmer Biomet inks pact with Oregon Surgical Institute to implement Zimmer Biomet Signature Solutions Outpatient Programme
14:00  [IST]ProBioGen inks second clinical immuno-oncology development contract with Tizona Therapeutics
13:00  [IST]NovaDigm begins phase 2a trial of NDV-3A in Staphylococcus aureus
more news >>
TOP NEWS
08:00  [IST]Easier norms may help Indian pharma manufacturers gain foothold in China market
08:00  [IST]Maha FDA's surprise inspections find no overcharging of stent prices by hospitals in Mumbai and Aurangabad
08:00  [IST]Authenticity and quality of herbs critical for product quality: Dr Babu U V
08:00  [IST]Healthcare experts stress on need for more regulations governing umbilical cord blood banking
08:00  [IST]NHM- Karnataka partners with Noora Health India to spur high-impact health skills for new-born care for family members
08:00  [IST]Medical device MNCs run the show at global standards organisation meetings, complex rules hurt MSMEs
more news >>
YESTERDAY'S NEWS
18:00  [IST]Philips showcases dedicated radiation oncology workflow solutions at ESTRO 2018
17:10  [IST]NRI stem cell scientist receives Bharat Gaurav award in the British parliament
17:00  [IST]Pfenex, NT Pharma ink development & license pact for Pfenex's PF708 therapeutic equivalent candidate to Forteo
16:00  [IST]PATH, Mologic enter agreement to advance new diagnostic test to support malaria elimination
15:30  [IST]Novartis appoints John Tsai as head of global drug development & CMO
15:00  [IST]US FDA clears OBI Pharma's IND application for phase I/II study of OBI-3424 targeting AKR1C3 solid tumors
more news >>
INTERVIEW  
Indian Pharma Inc shifts to high gear in filing patents
Ruhan Rajput, Director, Einfolge.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Chemspec_India-2018
IPE_2018_Banner_150X60
InnoPack-Pharma_150x60_2018
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
IPX_Logo_2018_150x60_web
CPHI18_banner_150x6
CPhI_China_150x60-2018
CPhI_Japan_150x60_2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
duphat_150x60
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |